A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

Three prospective randomized trials comparing the efficacy of preoperative and postoperative chemoradiotherapy in locally advanced rectal cancer were initiated between 1993 and 1994. 4,5 Two of ...

All had locally advanced cervical cancer, although none had tumors that had spread to other organs. The control group ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

How Was Keytruda Studied for Cervical Cancer? Keytruda was studied in ... People in this trial got either pembrolizumab plus chemoradiotherapy (chemotherapy plus radiation) or placebo plus ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

researchers performed a randomized phase 3 trial in which 813 patients with stage III or IVA endometrial cancer (median age, 60 years) were randomly assigned to receive either chemoradiotherapy (n ...

Keytruda (pembrolizumab) has been approved for use in combination with chemoradiotherapy (CRT) for patients with high-risk locally advanced cervical cancer; in other words, those with stage III to ...

Merck (NYSE:MRK) announced Friday that its anti-PD1 immunotherapy Keytruda, in combination with chemoradiotherapy ... high-risk locally advanced cervical cancer patients who received Keytruda ...

Ms Ingham underwent chemoradiotherapy and brachytherapy ... and hope that this can be done as quickly as possible." Cervical Cancer Prevention Week runs until January 28.